Product Description: Begelomab (SAND-26) is a murine IgG2b monoclonal antibody against DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy[1][2].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Lorenzo RD, et, al. Begelomab for severe refractory dermatomyositis: A case report. Medicine (Baltimore). 2021 Mar 5;100(9):e24372. /[2]Ojha R, et, al. Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2. Hum Immunol. 2022 Apr;83(4):346-355.
CAS Number: 1403744-56-8
Molecular Weight: N/A
Compound Purity: 95.0
Research Area: Inflammation/Immunology
Solubility: H2O
Target: Dipeptidyl Peptidase